To read the full story, subscribe or sign in.

Aventis Behring submits BLA for i.v. alpha1-proteinase inhibitor

Jan. 16, 2003

BioWorld Science Regulatory Respiratory

Today's news in brief

BioWorld

BioWorld briefs for July 21, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for July 21, 2026

To viral or not to viral: In vivo CAR T debates delivery tech

BioWorld

The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...

Click chemistry drug bound to pancreatic cancer cells from mice

In vivo click ADCs could address tumor heterogeneity

BioWorld

Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...

In the clinic for July 17, 2026

BioWorld

Clinical updates for biopharma and med tech, including data readouts and publications: AMT, Innocare, Insmed, Syntis, Telo Genomics.